Our Services

Blood and Marrow Transplantation (BMT) and Cellular Therapies

Description of Services


Our Mission

The clinical mission of the Division of Blood and Marrow Transplantation and Cellular Therapies is to design and test disease-specific and biologically rational novel reduced-toxicity transplantation regimens for patients with high-risk leukemia or lymphoma, and for those afflicted with life-threatening inherited conditions that can lead to bone marrow failure, immune deficiency, autoimmune diseases, and neurodegenerative conditions including but not limited to leukodystrophies and mucopolysaccharidosis syndromes.
Our translational research mission focuses on developing new cellular immune therapy programs for cancer and viral infections and testing the use of bone marrow transplantation following solid organ transplant to establish immunity, tolerance, and extend organ survival.


Comprehensive Care Expertise Environment
Comprehensive care Highly trained, highly respected Caring for the whole child and family
A Range of Services

We use blood and marrow transplant to treat cancers, blood diseases, and immune disorders once considered incurable.

Highly Trained, Highly Respected

Our doctors are pioneers in their respective fields, and are striving to improve cellular therapies for childhood cancers and blood diseases.

Caring for the Whole Child and Family 

We're dedicated to helping the child — and the entire family — through the BMT process.

  • Increase/Decrease Text Size
  • Print This Page
Last Update
December 11, 2014